Abionic

Abionic SA is a Swiss medtech company headquartered in Lausanne, Switzerland, specialized in medical devices and in vitro diagnostics. The device has tests including the sensitization to common respiratory allergies by measuring a patient's Immunoglobulin E (IgE) levels, iron deficiency tests, as well as tests for sepsis risk assessment and management.
History.
The company was founded in 2010 as a spinoff from the École Polytechnique Fédérale de Lausanne (EPFL, Swiss Federal Institute of Technology of Lausanne), by Dr. Nicolas Durand and Dr. Iwan Märki. In 2012 the company received ISO 13485 certification and the diagnostic platform, the abioSCOPE, was certified. In 2015 the first range of respiratory allergen diagnostics was developed and placed on the market. In 2016 the Ofac group was selected as Abionic's first distributor for the Swiss pharmacy market.
In 2017 the company received CE marking for its ferritin and sepsis tests. Abionic sponsored World Sepsis day, in order to raise awareness of sepsis on behalf of the Global Sepsis Alliance. Abionic obtained U.S. Food and Drug Administration registration for their first set of respiratory allergy diagnostics.
Products.
The abioSCOPE is a medical device that does immunoassay tests based on the ELISA principle.